Minoo Khalili Ghomi, Milad Noori, Maryam Mirahmad, Aida Iraji, Ahmad Shahir Sadr, Navid Dastyafteh, Pooria Asili, Mahdi Gholami, Shahrzad Javanshir, Maryam Lotfi, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Mehdi Asadi, Ensieh Nasli-Esfahani, Mahdie Palimi, Bagher Larijani, Mohammad Hadi Meshkatalsadat, Mohammad Mahdavi
The inhibition of the α-glucosidase enzyme is crucial for targeting type 2 diabetes mellitus (DM). This study introduces a series of synthetic analogs based on thiomethylacetamide-quinoline derivatives linked to diphenyl-imidazole as highly potential α-glucosidase inhibitors. Twenty derivatives were synthesized and screened in vitro against α-glucosidase, revealing IC50 values ranging from 0.18 ± 0.00 to 2.10 ± 0.07 μM, in comparison to the positive control, acarbose...
March 16, 2024: European Journal of Medicinal Chemistry